Northern Biologics

Northern Biologics utilizes cutting-edge antibody discovery to address new challenges in oncology and fibrosis. Its therapeutic antibody candidates are derived from the latest phage display platform developed and refined by world-leading researchers at the University of Toronto. Northern Biologics is committed to developing novel functional modulators of key signaling pathways in cancer and fibrosis.